BusinessAXIM Biotech Announces Successful Completion of Exploratory Meeting with the Dutch Medicines Evaluation Board on MedChew Rx Program for Treatment of Pain and Spasticity in MS PatientsBy Nasdaq OMXJan 23, 2018, 2:02 PM UTC
